{"title":"Can multispecific biologics break the efficacy ceiling?","authors":"Asher Mullard","doi":"10.1038/d41573-026-00106-5","DOIUrl":"10.1038/d41573-026-00106-5","url":null,"abstract":"A growing pipeline of multispecific antibody therapies are in clinical trials, showcasing novel biological effects as well as potential improvements over multi-agent cocktails. A growing pipeline of multispecific antibody therapies are in clinical trials, showcasing novel biological effects as well as potential improvements over multi-agent cocktails.","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"25 7","pages":"497-500"},"PeriodicalIF":91.2,"publicationDate":"2026-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148278178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Multispecific T-cell engagers attract cancer drug developers","authors":"Asher Mullard","doi":"10.1038/d41573-026-00107-4","DOIUrl":"10.1038/d41573-026-00107-4","url":null,"abstract":"Multispecific T-cell engagers that bind three or more targets on cancer and immune cells promise to address the shortcomings of their bispecific predecessors.","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"25 8","pages":"579-582"},"PeriodicalIF":91.2,"publicationDate":"2026-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148278145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Upcoming FDA approval decisions in Q3 2026","authors":"Swetha Kota","doi":"10.1038/d41573-026-00103-8","DOIUrl":"10.1038/d41573-026-00103-8","url":null,"abstract":"","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"25 7","pages":"506-506"},"PeriodicalIF":91.2,"publicationDate":"2026-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/d41573-026-00103-8.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148239698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The unglamourous AI wins that are quietly transforming drug discovery and development","authors":"Asher Mullard","doi":"10.1038/d41573-026-00099-1","DOIUrl":"10.1038/d41573-026-00099-1","url":null,"abstract":"David Reese, Amgen’s inaugural Chief Technology Officer, discusses how inconspicuous AI achievements stand to transform drug discovery. David Reese, Amgen’s inaugural Chief Technology Officer, discusses how inconspicuous AI achievements stand to transform drug discovery.","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"25 7","pages":"507-508"},"PeriodicalIF":91.2,"publicationDate":"2026-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/d41573-026-00099-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148239686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}